Eman M. Elhabashy, Wafaa H. Hussein, Geilan A. Mahmoud
{"title":"系统性红斑狼疮病程中的迟发性狼疮肾炎:与疾病活动性和治疗反应的关系","authors":"Eman M. Elhabashy, Wafaa H. Hussein, Geilan A. Mahmoud","doi":"10.1016/j.ejr.2024.12.005","DOIUrl":null,"url":null,"abstract":"<div><div><strong>Background:</strong> Lupus nephritis (LN) is severe organ involvement in systemic lupus erythematosus (SLE). It could be the first presentation, commonly in the first year after diagnosis, but may arise later during the disease course. The time of LN onset can affect its clinical presentation and disease outcomes. <strong>Aim of the work</strong>: To study the differences between early and delayed onset LN during the course of SLE and the prognosis of the disease. <strong>Patients and methods</strong>: This study included 100 SLE patients with LN. They were categorized into early onset group who developed LN within one year of diagnosis and delayed onset LN if developed after one year. Renal response to treatment was compared between early and delayed-onsets LN cases after six months, one year and two years of following up. <strong>Results</strong>: This study involved 100 SLE patient, 93 females and 7 males, the mean age was 36.6 ± 8.6 years with disease duration 9.7 ± 5.03 years. Early onset LN group included 45 patients while delayed-onset group included 55. At baseline, ESR and SELENA-SLEDAI were higher (p = 0.017 and 0.016 respectively) in early onset and renal biopsy showed higher cellular and fibrous crescents in the same group (p = 0.045 and 0.012 respectively). On the other hand, delayed onset LN group after 6 months, 1 and 2 years of following up showed more frequent flares with incomplete remission (p < 0.001, p = 0.002 and p < 0.001 respectively) and higher SELENA-SLEDAI (p < 0.001). <strong>Conclusion</strong>: Early onset LN has a better treatment response and presents a valuable indicator of complete remission than delayed-onset LN.</div></div>","PeriodicalId":46152,"journal":{"name":"Egyptian Rheumatologist","volume":"47 2","pages":"Pages 65-69"},"PeriodicalIF":1.0000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Delayed onset lupus nephritis in the course of systemic lupus erythematosus: Relation to disease activity and therapeutic response\",\"authors\":\"Eman M. Elhabashy, Wafaa H. Hussein, Geilan A. Mahmoud\",\"doi\":\"10.1016/j.ejr.2024.12.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><strong>Background:</strong> Lupus nephritis (LN) is severe organ involvement in systemic lupus erythematosus (SLE). It could be the first presentation, commonly in the first year after diagnosis, but may arise later during the disease course. The time of LN onset can affect its clinical presentation and disease outcomes. <strong>Aim of the work</strong>: To study the differences between early and delayed onset LN during the course of SLE and the prognosis of the disease. <strong>Patients and methods</strong>: This study included 100 SLE patients with LN. They were categorized into early onset group who developed LN within one year of diagnosis and delayed onset LN if developed after one year. Renal response to treatment was compared between early and delayed-onsets LN cases after six months, one year and two years of following up. <strong>Results</strong>: This study involved 100 SLE patient, 93 females and 7 males, the mean age was 36.6 ± 8.6 years with disease duration 9.7 ± 5.03 years. Early onset LN group included 45 patients while delayed-onset group included 55. At baseline, ESR and SELENA-SLEDAI were higher (p = 0.017 and 0.016 respectively) in early onset and renal biopsy showed higher cellular and fibrous crescents in the same group (p = 0.045 and 0.012 respectively). On the other hand, delayed onset LN group after 6 months, 1 and 2 years of following up showed more frequent flares with incomplete remission (p < 0.001, p = 0.002 and p < 0.001 respectively) and higher SELENA-SLEDAI (p < 0.001). <strong>Conclusion</strong>: Early onset LN has a better treatment response and presents a valuable indicator of complete remission than delayed-onset LN.</div></div>\",\"PeriodicalId\":46152,\"journal\":{\"name\":\"Egyptian Rheumatologist\",\"volume\":\"47 2\",\"pages\":\"Pages 65-69\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-01-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian Rheumatologist\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1110116424001054\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Rheumatologist","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1110116424001054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:狼疮肾炎(LN)是系统性红斑狼疮(SLE)的严重脏器累及。它可能是第一次出现,通常在诊断后的第一年,但也可能在病程的后期出现。LN的发病时间可影响其临床表现和疾病结局。研究目的:探讨SLE病程中早发性和晚发性LN的差异及其预后。患者和方法:本研究纳入100例SLE合并LN患者。他们被分为早发组,即在诊断一年内发展为LN,而迟发组则在一年后发展为LN。在随访6个月、1年和2年后,比较早期和迟发性LN患者对治疗的肾脏反应。结果:100例SLE患者,女性93例,男性7例,平均年龄36.6±8.6岁,病程9.7±5.03年。早发性LN组45例,迟发性LN组55例。在基线时,早期发病的ESR和SELENA-SLEDAI更高(p分别= 0.017和0.016),同一组的肾活检显示更高的细胞和纤维新月(p分别= 0.045和0.012)。另一方面,迟发性LN组在随访6个月、1年和2年后出现更频繁的不完全缓解(p <;0.001, p = 0.002, p <;0.001)和更高的SELENA-SLEDAI (p <;0.001)。结论:早发性LN具有更好的治疗效果,是迟发性LN完全缓解的重要指标。
Delayed onset lupus nephritis in the course of systemic lupus erythematosus: Relation to disease activity and therapeutic response
Background: Lupus nephritis (LN) is severe organ involvement in systemic lupus erythematosus (SLE). It could be the first presentation, commonly in the first year after diagnosis, but may arise later during the disease course. The time of LN onset can affect its clinical presentation and disease outcomes. Aim of the work: To study the differences between early and delayed onset LN during the course of SLE and the prognosis of the disease. Patients and methods: This study included 100 SLE patients with LN. They were categorized into early onset group who developed LN within one year of diagnosis and delayed onset LN if developed after one year. Renal response to treatment was compared between early and delayed-onsets LN cases after six months, one year and two years of following up. Results: This study involved 100 SLE patient, 93 females and 7 males, the mean age was 36.6 ± 8.6 years with disease duration 9.7 ± 5.03 years. Early onset LN group included 45 patients while delayed-onset group included 55. At baseline, ESR and SELENA-SLEDAI were higher (p = 0.017 and 0.016 respectively) in early onset and renal biopsy showed higher cellular and fibrous crescents in the same group (p = 0.045 and 0.012 respectively). On the other hand, delayed onset LN group after 6 months, 1 and 2 years of following up showed more frequent flares with incomplete remission (p < 0.001, p = 0.002 and p < 0.001 respectively) and higher SELENA-SLEDAI (p < 0.001). Conclusion: Early onset LN has a better treatment response and presents a valuable indicator of complete remission than delayed-onset LN.